<DOC>
	<DOC>NCT01400009</DOC>
	<brief_summary>Pretreating people with replacement doses of vitamin D will allow them to tolerate Statin medications that have caused muscle pain for them in the past.</brief_summary>
	<brief_title>Vitamin D Replacement in Statin-Induced Myopathy</brief_title>
	<detailed_description>Patients who have been unable to tolerate statin medications due to muscle pain will be randomly assigned to receive vitamin D or placebo for 6 weeks before reintroducing their statin medication. The investigators will judge whether vitamin D in the manner administered in the study reduces the myalgia with statins and allows patients to remain on these important medications.</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>male and female adults identified by their physician as having myalgia with their statin medication. Unexplained CK &gt; 4X upper limit of normal, at study entry, or on a statin medication in the past. Severe myositis Consumption in excess of 14 alcoholic beverages per week Situations which will cause difficulty in interpreting the vitamin D and / or PTH. examples: Present consumption of vitamin D supplements &gt; 1000 iu daily Renal impairment (Estimated creatinine clearance &lt; 70 ± 14 mL/min/m2 in Males; and &lt; 60 ± 10 mL/min/m2 in Females) Chronic liver disease or impaired liver function Any contraindication for statin rechallenge Example: rhabdomyolysis or allergy to statins</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Statin</keyword>
	<keyword>HMG COA Reductase Inhibitor</keyword>
	<keyword>myalgia</keyword>
	<keyword>vitamin D</keyword>
</DOC>